Insight Holdings Group, LLC

Insight Holdings Group (10% owner) liquidates entire 142.3K-share HNGE position for $10.2M via 10b5-1 plan

Insight Holdings Group filed a Form 4 on 2026-06-24 documenting two separate sales totaling 142,311 shares at $71.67, reducing its holdings from 142.3K shares to 0 shares (a -100.0% reduction). The transaction was executed under a pre-arranged 10b5-1 trading plan, indicating scheduled execution rather than discretionary timing. While the company shows strong recent momentum—30-day change +27.7%, 90-day change +75.6%—and posted revenue of $182.3M with net income of $35.1M in the latest quarter alongside 50.6% annual revenue growth, Insight Holdings' prior trades at HNGE show a mixed pattern, including four separate sales on 2025-12-01 that experienced subsequent 90-day declines of -10.5%. The complete exit is significant given the 10% ownership stake, though the scheduled nature of the 10b5-1 plan removes timing as an interpretive variable.

Insight Holdings Group, LLC sells 727,793 shares of HNGE for $51,634,252.32 under 10b5-1 plan; retains 26,497,370 derivative shares.

Insight Holdings Group, LLC, a 10% owner, executed 18 separate sales totaling 727,793 shares for $51,634,252.32 across three trading dates (June 22–24, 2026) at blended average price of $70.95. The transaction is part of a pre-arranged 10b5-1 trading plan, meaning it is scheduled rather than discretionary. While the non-derivative holding reaches 0 shares post-transaction, the insider retains substantial derivative holdings across 12 ownership vehicles totaling 26,497,370 shares of Class B Common Stock, so the overall position remains material. The stock currently trades at $70.56, near its 52-week high of $72.39, and has risen 27.7% over 30 days and 75.6% over 90 days. HNGE shows strong fundamentals with revenue of $182,307,000.00 and net income of $35,128,000.00 in the latest quarter, alongside annual revenue growth of +50.6%, though the company was unprofitable over its most recent full fiscal year.

Insight Holdings Group (10% owner) sells 65,581 shares at $70.36 via 4 scheduled transactions totaling $4.6M

Insight Holdings Group executed 4 separate sales totaling 65,581 shares for $4,614,252.93 at $70.36 on 2026-06-16, eliminating non-derivative holdings under a pre-arranged 10b5-1 trading plan. The company reported strong fundamentals with revenue of $182,307,000.00 and net income of $35,128,000.00 in the latest quarter, plus annual revenue growth of +50.6%, yet was unprofitable over its most recent full fiscal year. The sale occurred near the 52-week high ($70.72), with the stock at $69.42 currently. The insider's prior sales at HNGE on 2025-12-01 showed 30d returns of -2.7% and 90d returns of -10.5%, while an earlier 2025-05-23 sale posted 90d gains of +75.0%, indicating inconsistent timing outcomes at this ticker. As a scheduled trade under 10b5-1 rules, this represents pre-planned capital allocation rather than discretionary market timing.

10% Owner Insight Holdings Group sells 1,921,372 shares (1.92M) for $10,151,214.90 across 2 days at blended avg $5.28

Insight Holdings Group, a 10% owner, executed 10 separate sales totaling 1,921,372 shares for $10,151,214.90 on May 19-20, 2026, reducing its stake from 2,659,412 shares to 738,040 shares post-transaction. The stock is currently trading at $5.80, down -57.2% from its 52-week high of $13.56, and the company reported a net loss of $-20,500,000 in the latest quarter despite +9.0% annual revenue growth. The insider's cross-ticker track record shows a 90d well-timed rate of 93.33% across 20 prior sells, though the current transaction occurred as the stock declined -5.7% over the prior 30 days. The magnitude of this exit—reducing holdings by -72.2%—combined with the company's unprofitable status and significantly depressed valuation warrants investor attention to the insider's confidence level.

10% Owner Insight Holdings divests 1,654,440 shares ($79.0M) at $47.76; post-sale holdings near zero per derivative conversion.

Insight Holdings Group, LLC, a 10% owner of Hinge Health, executed 4 separate sales on 2025-12-01 totaling 1,654,440 shares (1.65M shares) for $79,016,054.40 ($79.0M) at a blended average price of $47.76. The filing flags a derivative-conversion transaction, meaning the shareholder's true residual position is held in derivative securities (Table II), not reflected in the Table I share count—so this should not be characterized as a complete liquidation. The current stock price is $46.02, down 8.6% over 30 days and 17.8% over 90 days, trading 24.0% below its 52-week high of $60.55. Across the insider's cross-ticker track record, prior sells have averaged -5.1% 30-day return and -13.3% 90-day return with a 93.33% well-timed rate, indicating a historical tendency to exit before declines. At the same ticker (HNGE), the insider's single prior sell on 2025-05-23 turned out poorly timed (90d return +75.0%, meaning the stock rose after the sale). The company's fundamentals show revenue of $154,211,000.00 in the latest quarter against a net loss of $1,844,000.00, reflecting ongoing profitability pressure.

Director Insight Holdings Group, LLC sells entire 49.83M share stake for $164.4M at $3.30 on 2025-08-03.

Insight Holdings Group, LLC executed 5 separate sales totaling 49,831,007 shares for $164,442,323.10, completely exiting its director position in ETWO at $3.30/share. The company is unprofitable with full-year negative net income and declining revenue growth (-4.2% annually), yet the insider's cross-ticker track record shows a 100.00% 90d well-timed rate across 20 prior sells with an average 90d return of -19.2%, indicating historically strong sell timing. The complete liquidation of a 49.83M share position by a director—representing elimination of the entire holding—warrants investor scrutiny given the timing coincides with a stock price that is -29.3% from its 52-week high and the company's unprofitable fundamentals.

Insight Holdings Group (10% owner) sells 1,250,000 shares of HNGE at $32.00 for $40,000,000 total

Insight Holdings Group, a 10% stakeholder in Hinge Health, sold 1,250,000 shares (1.25M shares) at $32.00 on 2025-05-23 for $40,000,000, reducing their shareholding from 1,250,000 shares to 0 shares in the common equity position shown in Table I. The transaction occurs in the immediate post-listing window (3 trading days after HNGE's recent IPO), when price discovery is still volatile and early lock-up expirations typically influence secondary market activity. However, this filing contains a derivative-conversion component that is not yet fully populated in our database, meaning the insider's real position extends to Form 4 Table II derivative securities—this should not be characterized as a complete position exit. The sale price of $32.00 compares to a current market price of $42.13 as of 2025-05-27, suggesting the insider sold below the emerging post-IPO equilibrium price.

Insight Holdings Group sells 665.7K NCNO shares for $24.3M across 8 transactions; stake reduced 68.5% to 306.0K shares

Insight Holdings Group, a director of nCino, executed 8 separate sales totaling 665,664 shares for $24,291,053.07 across December 9–10, 2024, reducing its holdings from 971,706 shares to 306,042 shares (a -68.5% reduction in stake size). The sales occurred at blended average price $36.49, near current price of $36.41; the insider retained a material 306.0K share position post-transaction. The company is unprofitable (full-year net income was negative) and currently trading -14.6% from its 52-week high of $42.64, though it has posted +25.1% return over 90 days. The magnitude and structure of this multi-tranche liquidation—retaining only one-third of prior holdings while eliminating two-thirds—represents a substantial reduction in director-level exposure to the company.

Insight Holdings Group sells 314.8K shares of NCNO for $11.5M across two days; reduces stake 27.1% to 846.7K shares

Insight Holdings Group, LLC (Director) executed 8 separate sales totaling 314,766 shares for $11,486,271.88 between 2024-12-09 and 2024-12-10, reducing its NCNO holdings by 27.1% from 1,161,438 to 846,672 shares. The sales occurred at a blended average price of $36.49, just above the current price of $36.41, with prices ranging from $37.27 on December 9 to $36.18 on December 10. nCino remains unprofitable—posting a net loss of $5,252,000 on quarterly revenue of $138,797,000—though the company achieved annual revenue growth of 16.7%. The multi-day, multi-transaction structure and the material reduction in directional stake warrants investor attention to understand the motivation and any broader signals about the company's near-term outlook.

Insight Holdings Group director sells 575,612 shares for $21.0M (12/9–12/10); reduces stake 35.0% to 1.07M shares

Insight Holdings Group, LLC, a director of nCino, executed 8 separate sales totaling 575,612 shares for $21,004,923.46 over two consecutive trading days at prices ranging from $36.18 to $37.27 (blended average $36.49). This transaction reduced the director's stake by 35.0%, from 1,643,626 shares to 1,068,014 shares post-transaction. The sales occurred when the stock stood near its 52-week high—only 14.6% below the $42.64 peak—and 2.2% above the current price of $36.41, suggesting execution near elevated levels. The company remains unprofitable (full-year net income was negative; latest quarter net income was $-5,252,000.00) despite 16.7% annual revenue growth and $138,797,000.00 in quarterly revenue, which may have motivated the reduction in a $4.2B market-cap firm still loss-making.